The U.S. Food and Drug Administration (FDA) has approved the first generic version of Victoza (liraglutide injection), a glucagon-like peptide-1 (GLP-1) receptor...
By navigating our site, you agree to allow us to use cookies, in accordance with our Privacy Policy.